In approximately 40% of CRC patients, tumours harbour mutations in the v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS), mainly in codons 12, 13, and 616,7. This evidence concerns the gene KRAS and neoplasm.